Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...

Lupin introduces ipratropium bromide nasal solution, 0.03% & 0.06% in US markets: Our Bureau, Mumbai Friday, July 4, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin ...

Lupin announced the launch of Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in the United States. Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% are ...

Ipratropium bromide nasal solution (Nasal Spray) 0.03% is indicated for the symptomatic relief of rhinorrhea associated with ...

Lupin launches Ipratropium Bromide nasal spray in US, bioequivalent to Atrovent. The product addresses rhinitis and targets a $63 million market opportunity.

Lupin launches Ipratropium Bromide nasal spray for treating runny nose in the US market. Available in 0.03% and 0.06% ...

Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...

Getting a cold once or twice a few months is normal, but what about a persistently blocked nose that lingers for weeks and ...

When it comes to the fentanyl crisis, the Seattle Public Library is pairing education with action by offering from naloxone ...

Probation officials said youths and staff members were hospitalized after a 'suspected overdose and possible exposure to an ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...